Back to News
Market Impact: 0.1

Detailed Fundamental Analysis

VYMNDAQ
Company FundamentalsAnalyst InsightsCapital Returns (Dividends / Buybacks)Interest Rates & YieldsHealthcare & Biotech
Detailed Fundamental Analysis

The Vanguard High Dividend Yield ETF (VYM) is identified as a Large-Cap Multi-Factor ETF, primarily allocated to the Financial sector and the Biotechnology & Drugs industry. Its fundamental factor analysis reveals a strong exposure to Low Volatility (score 89), complemented by significant tilts towards Value (71), Quality (66), and Momentum (63), suggesting a defensive yet fundamentally-driven investment profile.

Analysis

The Vanguard High Dividend Yield ETF (VYM) presents a distinct profile as a Large-Cap Multi-Factor fund, according to a Validea fundamental report. The ETF demonstrates an exceptionally strong exposure to the Low Volatility factor, with a score of 89 out of 99, indicating a significant defensive characteristic. This is complemented by a solid tilt towards Value, with a score of 71, and robust exposure to Quality and Momentum, scoring 66 and 63 respectively. This combination suggests a strategy that prioritizes downside protection and fundamental strength over aggressive growth. The portfolio's largest sector concentration is in Financials, with its top industry exposure being Biotechnology & Drugs, which are key determinants of its performance and risk profile. The balanced, above-average scores across all four measured factors imply a well-rounded construction aimed at delivering yield without excessively compromising on other desirable investment characteristics.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

NDAQ0.00
VYM0.30

Key Decisions for Investors

  • Investors seeking a defensive, income-oriented core holding may find VYM attractive due to its exceptionally high Low Volatility score of 89 and strong Value factor exposure of 71.
  • Portfolio managers should note the ETF's significant concentration in the Financial and Biotechnology & Drugs sectors, as performance will be heavily influenced by the specific catalysts and risks affecting these industries.
  • The fund's balanced scores across Value (71), Quality (66), and Momentum (63) suggest it could serve as a single-instrument solution for investors looking to implement a multi-factor strategy within the large-cap space.
  • Given its high Quality score (66), the ETF appears to screen for fundamentally sound companies, which may mitigate the risks typically associated with high-yield chasing strategies and appeal to long-term, risk-aware investors.